测量结构性种族主义与歧视对胃肠病和肝病结局影响的工具:范围综述
本范围综述遵循PRISMA-ScR指南,纳入46篇文章(19篇使用结构性种族主义与歧视测量工具,27篇为上游干预研究)。居住种族隔离测量报告最多,结构性种族主义与种族和族裔少数人群较差的健康结局相关;上游干预主要针对结肠癌筛查和器官移植分配政策,但干预后种族和族裔差异常持续存在。
要点
- 居住种族隔离是胃肠病和肝病研究中报告最多的结构性种族主义测量指标。
- 结构性种族主义与种族和族裔少数人群较差的胃肠病和肝病健康结局相关。
- 针对结肠癌筛查和器官移植分配的上游干预后,种族和族裔差异常持续存在。
核心结论
- 为实现胃肠病和肝病领域的健康公平,亟需超越描述健康差异的研究,纳入结构性种族主义与歧视的测量并实施针对这一研究不足的健康决定因素的干预。
研究设计与样本
- 范围综述,遵循系统综述和Meta分析范围综述首选报告条目(PRISMA-ScR)指南。
- 纳入使用结构性种族主义与歧视测量工具或考察胃肠病或肝病上游干预的研究。
- 排除仅描述胃肠病或肝病健康差异但未提及结构性种族主义与歧视的研究。
- 共纳入46篇文章,其中19篇使用结构性种族主义与歧视测量工具,27篇为上游干预研究。
主要发现
- 居住种族隔离的测量报告最为频繁。
- 结构性种族主义与歧视与种族和族裔少数人群较差的健康结局相关。
- 上游干预研究主要聚焦于结肠癌筛查和器官移植分配相关政策。
- 种族和族裔差异在干预后常持续存在。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Structural racism and discrimination (SRD) are important upstream determinants of health perpetuated by discriminatory laws and policies. Therefore, measuring SRD and its impact on health is critical to developing interventions that address resultant health disparities. We aimed to identify gastrointestinal (GI) or liver studies that report measures of SRD or interventions to achieve health equity in these domains by addressing upstream determinants of health. METHODS: We conducted a scoping review according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses scoping reviews guidelines. Studies that used an SRD measure or examined an upstream intervention in GI or liver disease were included. Studies that described health disparities in GI or liver conditions without mentioning SRD were excluded. Study characteristics, findings, and limitations were extracted. RESULTS: Forty-six articles (19 studies using SRD measures and 27 studies of upstream interventions) were identified. Measures of residential racial segregation were reported most frequently. SRD was associated with poorer health outcomes for racial and ethnic minority populations. Although upstream intervention studies focused primarily on policies related to colon cancer screening and organ graft allocation, racial and ethnic disparities often persisted post-intervention. CONCLUSIONS: To achieve health equity in GI and liver conditions, there is an urgent need for research that goes beyond describing health disparities to incorporating measures of SRD and implementing interventions that address this understudied determinant of health.
引用
- Liu JJ, DeCuir N, Kia L, et al. Tools to Measure the Impact of Structural Racism and Discrimination on Gastrointestinal and Hepatology Disease Outcomes: A Scoping Review. Clin Gastroenterol Hepatol. 2022. PMID: 36549469. doi:10.1016/j.cgh.2022.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。